The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis
Open accessAbstract
Bone metastasis is mediated by complex interactions between tumor cells and resident stromal cells in the bone microenvironment. The functions of metalloproteinases in organ-specific metastasis remain poorly defined despite their well-appreciated role in matrix degradation and tumor invasion. Here, we show a mechanism whereby two distinct metalloproteinases, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS1) and matrix metalloproteinase-1 (MMP1), orchestrate a paracrine signaling cascade to modulate the bone microenvironment in favor of osteoclastogenesis and bone metastasis. Proteolytic release of membrane-bound epidermal growth factor (EGF)-like growth factors, including Amphiregulin (AREG), heparin-binding EGF (HB-EGF), and transforming growth factor α (TGFα) from tumor cells suppress the expression of osteoprotegerin (OPG) in osteoblasts and subsequently potentiate osteoclast differentiation. EGF receptor (EGFR) inhibitors block osteolytic bone metastasis by targeting EGFR signaling in bone stromal cells. Furthermore, elevated MMP1 and ADAMTS1 expression is associated with increased risk of bone metastasis in breast cancer patients. This study established MMP1 and ADAMTS1 in tumor cells, as well as EGFR signaling in osteoblasts, as promising therapeutic targets for inhibiting bone metastasis of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Self-citationERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Self-citationMetastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Matrix metalloproteinases and the regulation of tissue remodelling
Page-McCaw, A., Ewald, A. J., & Werb, Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2125 · Cited by 2,630
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Self-citationStrategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Mitchell, P. G., Magna, H. A., Reeves, L. M., Lopresti-Morrow, L. L., Yocum, S. A., Rosner, P. J., Geoghegan, K. F., & Hambor, J. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118475 · Cited by 940
BindingDB (2025) · PubMed · doi:10.7270/q2pc374f · Cited by 924
Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
PORTER, S., CLARK, I. M., KEVORKIAN, L., & EDWARDS, D. R. (2005) · Biochemical Journal · doi:10.1042/bj20040424 · Cited by 779
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
Minn, A. J., Kang, Y., Serganova, I. S., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R. G., & Massagué, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522320 · Cited by 742
Self-citationMediators of vascular remodelling co-opted for sequential steps in lung metastasis
Gupta, G. P., Nguyen, D. X., Chiang, A. C., Bos, P. D., Kim, J. Y., Nadal, C., Gomis, R. R., Manova-Todorova, K., & Massagué, J. (2007) · Nature · doi:10.1038/nature05760 · Cited by 727
Self-citationMoulder, S. L., Yakes, F. M., Muthuswamy, S. K., Bianco, R., Simpson, J. F., & Arteaga, C. L. (2001) · PubMed · Cited by 597
ADAMs in cancer cell proliferation and progression
Mochizuki, S., & Okada, Y. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00434.x · Cited by 546
Kuno, K., Kanada, N., Nakashima, E., Fujiki, F., Ichimura, F., & Matsushima, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.556 · Cited by 504
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
Dr. Harris, S. A., Enger, R. J., Riggs, L. B., & Spelsberg, T. C. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100203 · Cited by 488
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
Yin, J. J., Mohammad, K. S., Käkönen, S. M., Harris, S., Wu-Wong, J. R., Wessale, J. L., Padley, R. J., Garrett, I. R., Chirgwin, J. M., & Guise, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1830978100 · Cited by 381
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9392-8 · Cited by 374
Interstitial collagenases as markers of tumor progression.
Brinckerhoff, C., Rutter, J. L., & Benbow, U. (2000) · PubMed · Cited by 339
Yoneda, T., Sasaki, A., Dunstan, C., Williams, P. J., Bauss, F., De Clerck, Y. A., & Mundy, G. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119435 · Cited by 247
Glinsky, V. V., Glinsky, G. V., Rittenhouse‐Olson, K., Huflejt, M. E., Glinskii, O. V., Deutscher, S. L., & Quinn, T. P. (2001) · PubMed · Cited by 239
Price, J. T., Tiganis, T., Agarwal, A., Djakiew, D., & Thompson, E. W. (1999) · PubMed · Cited by 238
Platelet and osteoclast β 3 integrins are critical for bone metastasis
Bakewell, S. J., Nestor, P., Prasad, S., Tomasson, M. H., Dowland, N., Mehrotra, M., Scarborough, R., Kanter, J., Abe, K., Phillips, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234372100 · Cited by 233
Nemeth, J. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.17 · Cited by 221
Kos, C. H., Karaplis, A. C., Peng, J.-B., Hediger, M. A., Goltzman, D., Mohammad, K. S., Guise, T. A., & Pollak, M. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17416 · Cited by 209
Epidermal growth factor receptor
Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P. J., Ward, C. W., & Burgess, A. W. (2003) · The EGF Receptor Family · doi:10.1016/b978-012160281-9/50004-9 · Cited by 181
Ibbotson, K. J., Harrod, J., Gowen, M., D'Souza, S., Smith, D. D., Winkler, M. E., Derynck, R., & Mundy, G. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2228 · Cited by 179
Poola, I., DeWitty, R. L., Marshalleck, J. J., Bhatnagar, R., Abraham, J., & Leffall, L. D. (2005) · Nature Medicine · doi:10.1038/nm1243 · Cited by 174
Identification of matrix metalloproteinase 9 in rabbit osteoclasts.
Tezuka, K., Nemoto, K., Tezuka, Y., Sato, T., Ikeda, Y., Kobori, M., Kawashima, H., Eguchi, H., Hakeda, Y., & Kumegawa, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36566-3 · Cited by 167
Liu, Y.-J., Xu, Y., & Yu, Q. (2006) · Oncogene · doi:10.1038/sj.onc.1209287 · Cited by 167
Molecular Mechanisms of Breast Cancer Metastases to Bone
Guise, T. A., Kozlow, W. M., Heras-Herzig, A., Padalecki, S. S., Yin, J. J., & Chirgwin, J. M. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.s.004 · Cited by 167
Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone
Phadke, P. A., Mercer, R. R., Harms, J. F., Jia, Y., Frost, A. R., Jewell, J., Bussard, K. M., Nelson, S. M., Moore, C., Kappes, J. C., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1806 · Cited by 124
Takahashi, N., MacDonald, B. R., Hon, J. K., Winkler, M., Derynck, R., Mundy, G. R., & Roodman, G. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112677 · Cited by 120
Wang, K., Yamamoto, H., Chin, J. R., Werb, Z., & Vu, T. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403114200 · Cited by 118
Zhu, J., Jia, X., Xiao, G., Kang, Y., Partridge, N. C., & Qin, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705064200 · Cited by 109
Self-citationNormanno, N., Luca, A. D., Aldinucci, D., Maiello, M. R., Mancino, M., D’Antonio, A., Filippi, R. D., & Pinto, A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00956 · Cited by 99
Expression of Epidermal Growth Factor in Transgenic Mice Causes Growth Retardation
Chan, S. Y., & Wong, R. W.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004189200 · Cited by 74
Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines
Rood, Calafat, Borne, K. V. D., Gerritsen, & Schoot, V. D. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00672.x · Cited by 71
Winding, B., NicAmhlaoibh, R., Misander, H., Høegh-Andersen, P., Andersen, T. L., Holst‐Hansen, C., Heegaard, A., Foged, N. T., Brünner, N., & Delaissé, J. (2002) · PubMed · Cited by 68
The effect of Neovastat (Æ-941) on an experimental metastatic bone tumor model
Weber, M. H., Lee, J., & Orr, F. W. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.2.299 · Cited by 62
Lee, J., Weber, M. H., Mejia, S., Bone, E. A., Watson, P. H., & Orr, W. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00363-4 · Cited by 60
Lorenzo, J. A., Quinton, J., Sousa, S., & Raisz, L. G. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112517 · Cited by 51
Reponen, P., Sahlberg, C., Munaut, C., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24789.x · Cited by 45
Cheng, S., Tada, M., Hida, Y., Asano, T., Kuramae, T., 竹本, 法., Hamada, J., Miyamoto, M., Hirano, S., Kondo, S., et al. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.05.032 · Cited by 41
Arguello, F., Furlanetto, R. W., Baggs, R. B., Graves, B. T., Harwell, S. E., Cohen, H., & Frantz, C. N. (1992) · PubMed · Cited by 40
Rucci, N., Ricevuto, E., Ficorella, C., Longo, M., Perez, M., Giacinto, C. D., Funari, A., Teti, A. M., & Migliaccio, S. (2004) · Bone · doi:10.1016/j.bone.2003.07.012 · Cited by 30
Normanno, N. (2005) · Frontiers in bioscience · doi:10.2741/1725 · Cited by 24
Matrix Metalloproteinaes and Bone Metastasis
Bonfil, R. D., Osenkowski, P., Fridman, R. A., & Cher, M. L. (2004) · Cancer treatment and research · doi:10.1007/978-1-4419-9129-4_8 · Cited by 14
Cited by
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
“A similar effect has recently been elucidated for MMP-1 and ADAMTS-1 by knocking down these proteases in a highly bone-metastatic clone of the human breast cancer cell line MDA-MB-231 (Lu et al., 2009).”
BackgroundConcepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Metastatic colonization by circulating tumour cells
Massagué, J., & Obenauf, A. C. (2016) · Nature · doi:10.1038/nature17038 · Cited by 2,062
Self-citationPre-metastatic niches: organ-specific homes for metastases
Peinado, H., Zhang, H., Matei, I. R., Costa-Silva, B., Hoshino, A., Rodrigues, G., Psaila, B., Kaplan, R. N., Bromberg, J. F., Kang, Y., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.6 · Cited by 1,889
Self-citationCancer to bone: a fatal attraction
Weilbaecher, K. N., Guise, T. A., & McCauley, L. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3055 · Cited by 1,285
Metadata
- Authors
- Lu, X., Wang, Q., Hu, G., Van Poznak, C., Fleisher, M., Reiss, M., Massagué, J., & Kang, Y.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2009-07-16
- Volume
- 23
- Issue
- 16
- Pages
- 1882-1894
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2127094853
- Cited by
- 304
- References
- 53
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.